| Catalog Number | KRP644 |
| Alias | V型和免疫球蛋白结构域含有蛋白4, V-set and immunoglobulin domain-containing protein 4 , Protein Z39Ig, CRIg, Z39IG, UNQ317/PRO362, V-set and immunoglobulin domain-containing protein 4 |
| Size | 20ug, 50ug, 100ug, 200ug, 1mg |
| Product Description | Human VSIG4(Arg20-Pro283) |
| Molecular Name | VSIG4 |
| Product Introduction | V型和免疫球蛋白结构域含有蛋白4参与细胞信号转导，调节免疫反应。。 |
| Molecular Weight | 48 kDa |
| Expression System | HEK293F Cells |
| Species | Human |
| Concentration | 联系销售经理获得最新批次的浓度 |
| Purity | ≥95% |
| SDS-PAGE | |
| Purification | Affinity Purification |
| Uniprot ID | Q9Y279 |
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. |
| Formulation | Supplied in PBS |
| Shipping Condition | This product is shipped on ice packs or dry ice. |
| Background | Phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. Potent inhibitor of the alternative complement pathway convertases. {ECO:0000269|PubMed:17016562, ECO:0000269|PubMed:17051150}. |
| Endotoxin | < 0.1 EU per ug |
| Biological Activity | Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 0.5-3 μg/mL. |
| Product Declaration | 该产品仅供科研使用，不可直接用于人体或注射。 |
销售微信
官方公众号
0
